Global Biological Safety Testing Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)
Global Biological Safety Testing Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)
Market Segmentation: By Product (Reagents and Kits, Instruments, and Other Products), Application (Vaccines and Therapeutics, Cellular and Gene Therapy, Blood and Blood-based Therapy, and Other Applications), Test (Sterility Tests, Bioburden Tests, Endotoxin Tests, and Other Tests), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Market Overview
The Global Biological Safety Testing Market was valued at USD 4,604.2 million in 2023 and is expected to reach USD 10,383.4 million by 2031 while growing at a CAGR of 10.7% during the forecast period (2024-2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Market Dynamics
This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global biological safety testing market growth. Biological safety testing ensures the safety of products like pharmaceuticals and vaccines. It assesses potential risks, confirms adherence to safety standards, and is crucial for public health and patient safety.
The anticipated growth in the biological safety testing market is driven by the increase in Biopharmaceutical R&D and technological advancements, including automation and improved testing methodologies. However, obstacles such as the Stringent Regulatory Environment and High Cost of Testing may impede market expansion despite the potential.
Furthermore, the global biological safety testing industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.
Segmentation – By Product Analysis
The Global Biological Safety Testing Market is segmented among Reagents and Kits, Instruments, and Other Products, based on product. In 2023, Reagents and Kits accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Segmentation – By Application Analysis
The Global Biological Safety Testing Market is segmented among Vaccines and Therapeutics, Cellular and Gene Therapy, Blood and Blood-based Therapy, and Other Applications, based on Application. In 2023, Vaccines and Therapeutics accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Global Biological Safety Testing Market: Regional Analysis
Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Competitive Landscape
Some of the key players operating in the market are Avance Biosciences, Cytovance Biologics, Eurofins Scientific, Lonza, Merck KGaA, Promega Corporation, Thermo Fisher Scientific, Toxikon, WuXi AppTec, and Biomerieux SA.
Table of Contents:
1. Research Methodology and Market Scope
Research Methodology
Market Scope
2. Executive Summary
3. Global Biological Safety Testing Market Dynamics
Drivers
Restraints
Opportunity
4. Global Biological Safety Testing Industry Analysis
PEST Analysis
Porter's Five Force Analysis
Recent Deals Analysis
5. Global Biological Safety Testing Market Segmentation, By Product
Global Biological Safety Testing Market Share Analysis, By Product
Global Biological Safety Testing Market Growth Analysis, By Product
Global Biological Safety Testing Market Trends, By Product
o Reagents and Kits
o Instruments
o Other Products
6. Global Biological Safety Testing Market Segmentation, By Application
Global Biological Safety Testing Market Share Analysis, By Application
Global Biological Safety Testing Market Growth Analysis, By Application
Global Biological Safety Testing Market Trends, By Application
o Vaccines and Therapeutics
o Cellular and Gene Therapy
o Blood and Blood-based Therapy
o Other Applications
7. Global Biological Safety Testing Market Segmentation, By Test
Global Biological Safety Testing Market Share Analysis, By Test
Global Biological Safety Testing Market Growth Analysis, By Test
Global Biological Safety Testing Market Trends, By Test
o Sterility Tests
o Bioburden Tests
o Endotoxin Tests
o Other Tests
8. Global Biological Safety Testing Market Segmentation, By Region
Global Biological Safety Testing Market Share Analysis, By Region
Global Biological Safety Testing Market Growth Analysis, By Region
Global Biological Safety Testing Market Trends, By Region
o North America
o Europe
o Asia Pacific
o Latin America
o Middle East
o Africa
9. Competitive Landscape
Avance Biosciences*
o Company Overview
o Financial Performance
o Key Development/Strategies
o SWOT Analysis
Cytovance Biologics
Eurofins Scientific
Lonza
Merck KGaA
Promega Corporation
Thermo Fisher Scientific
Toxikon
WuXi AppTec
Biomerieux SA
*Similar analysis will be provided for each company listed above.
